Evaluation of Clinical, Metabolic, and Physical-functional Effects of Systemic Vibratory Therapy in Metabolic Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-01

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies have demonstrated a strong relationship between physical inactivity and the presence of cardiovascular risk factors such as hypertension, insulin resistance, diabetes, dyslipidemia, obesity, and metabolic syndrome. On the other hand, regular physical exercise has been recommended to prevent and treat cardiovascular diseases, their risk factors, and other chronic conditions. Systemic vibration therapy (SVT) has been proposed as an alternative exercise modality for this population.

This project aimed to assess clinical, metabolic, physical, functional, biochemical parameters, quality of life, and sleep quality in individuals with metabolic syndrome undergoing whole-body vibration exercises on a vibratory platform.

This study aimed to evaluate clinical, metabolic, physical-functional, biochemical parameters, quality of life, and sleep quality in individuals with MSy undergoing whole-body vibration exercises. Assessments were conducted before and after the intervention and included cardiovascular responses, dyspnea, fatigue, anthropometric measurements (neck, abdominal, hip, arm, and ankle circumferences), body composition, anterior trunk and lumbar spine flexibility, and laboratory analyses (complete blood count, cholesterol profile, triglycerides, creatinine, uric acid, cortisol, glucose, insulin, growth hormone, vitamin D, and other biomarkers). Questionnaires assessed quality of life and sleep. Neuromuscular function, handgrip strength, lower limb isometric dynamometry, joint goniometry, and functional tests were evaluated.

Participants were randomized into two SVT protocol groups: Fixed Frequency (FF) and Variable Frequency (VF). Both protocols were conducted on a vibratory platform with alternating base displacement.

In the FF group, a frequency of 5 Hz was applied, with peak-to-peak displacements of 2.5, 5.0, and 7.5 mm, a work time of 1 minute (10s "on" and 50s "off"), and 1 minute of rest in an upright position. In the VF group, frequencies varied from 5 to 16 Hz (increasing by 1 Hz per session), with a work time of 1 minute and 1 minute of rest, while peak-to-peak displacements remained the same as in the FF protocol. The protocols were performed in static and dynamic squat positions, twice a week, over six weeks, totaling 12 sessions.

It is expected that this vibratory platform intervention can improve clinical, physical, biochemical, and functional parameters, as well as quality of life and sleep quality in individuals with MSy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Whole-body Vibration on TcPO2

NCT03957811

Diabetes Mellitus, Type 2

UNKNOWN PHASE3

Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals

NCT03306056

Overweight and Obesity Metabolic Syndrome

UNKNOWN NA

Effect of Exercise on Endothelial Injury in Hypertensive Patients

NCT02937922

Hypertension Healthy

COMPLETED NA

Resistance Training and Metabolic Syndrome

NCT02918448

Metabolic Syndrome

COMPLETED PHASE2

Metabolism of Obese Women Under Exercise and Recovery Hypoxia

NCT05380830

Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For anamnesis, participant data were collected, including age, sex, smoking status, alcohol consumption, presence and type of diabetes mellitus, presence of systemic arterial hypertension, associated comorbidities, medication use, history of COVID-19, and physical inactivity.

Clinical assessments were conducted before and after the 12 sessions of systemic vibratory therapy, including measurements of systemic blood pressure, heart rate, respiratory rate, the BORG scale, the Numeric Pain Scale (NPS), and the Rating of Perceived Exertion (RPE scale - subjective effort perception). Anthropometric measurements were collected, including neck, abdominal, hip, arm, and ankle circumferences, as well as body composition distribution assessed via bioelectrical impedance, anterior trunk flexibility via the sit-and-reach test (FAT), and lumbar spine flexibility via the Schober test.

Laboratory analyses of relevant biomarkers, the HOMA-IR index, and anthropometric indicators were also evaluated. Questionnaires were administered to assess quality of life and sleep quality.

Neuromuscular activity was assessed using surface electromyography, handgrip strength via a manual dynamometer, lower limb isometric dynamometry, joint goniometry, and functional tests. Patients were positioned on the platform base under the supervision of a healthcare professional to perform the interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Metabolic Syndrome Obesity Metabolic Syndrome X

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fixed Frequency (FF)

In the FF group, a frequency of 5Hz, peak-to-peak displacements of 2.5, 5.0, and 7.5 mm, with 1 min of working time with 10s "on" and 50s "off" and 1 min of rest, were used. During the protocol, the individuals performed static and dynamic squats (intercalated days). One minute of vibration and one minute without vibration were performed in each peak-to-peak displacement, which corresponds to one sequence (one series). From the 1st to the 4th session, 3 sequences were performed (totaling 18 minutes); from the 5th to the 8th session, 4 sequences were performed (totaling 24 minutes); and from the 9th to the 12th session, 5 sequences were performed (totaling 30 minutes).

Group Type ACTIVE_COMPARATOR

Systemic vibratory therapy

Intervention Type DEVICE

The interventions were performed on a vibratory platform with side-alternating displacement of the base (Novaplate Fitness Evolution model, DAF Produtos Hospitalares Ltda, São Paulo). The individual was positioned barefoot, with knees flexed at 130º on the base of the vibratory platform. The protocol was performed over a 6-week period with 2 weekly sessions, totaling 12 sessions. The frequency was 5-16Hz according the protocol, and the peak-to-peak displacement was 2.5, 5.0, and 7.5 mm in all sessions. During the protocol, the individuals performed static and dynamic squats, with one static and one dynamic session (interleaved). The variables were evaluated before and after the interventions.

Varied Frequency (VF)

In the VF group, frequencies ranged from 5 to16 Hz (increasing 1 Hz with each session), the work time was 1 min and 1 min rest, and the peak-to-peak displacements of 2.5, 5.0, and 7.5 mm. During the protocol, the individuals performed static and dynamic squats (intercalated days). One minute of vibration and one minute without vibration were performed in each peak-to-peak displacement, which corresponds to one sequence (one series). From the 1st to the 4th session, 3 sequences were performed (totaling 18 minutes); from the 5th to the 8th session, 4 sequences were performed (totaling 24 minutes); and from the 9th to the 12th session, 5 sequences were performed (totaling 30 minutes).

Group Type ACTIVE_COMPARATOR

Systemic vibratory therapy

Intervention Type DEVICE

The interventions were performed on a vibratory platform with side-alternating displacement of the base (Novaplate Fitness Evolution model, DAF Produtos Hospitalares Ltda, São Paulo). The individual was positioned barefoot, with knees flexed at 130º on the base of the vibratory platform. The protocol was performed over a 6-week period with 2 weekly sessions, totaling 12 sessions. The frequency was 5-16Hz according the protocol, and the peak-to-peak displacement was 2.5, 5.0, and 7.5 mm in all sessions. During the protocol, the individuals performed static and dynamic squats, with one static and one dynamic session (interleaved). The variables were evaluated before and after the interventions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Systemic vibratory therapy

The interventions were performed on a vibratory platform with side-alternating displacement of the base (Novaplate Fitness Evolution model, DAF Produtos Hospitalares Ltda, São Paulo). The individual was positioned barefoot, with knees flexed at 130º on the base of the vibratory platform. The protocol was performed over a 6-week period with 2 weekly sessions, totaling 12 sessions. The frequency was 5-16Hz according the protocol, and the peak-to-peak displacement was 2.5, 5.0, and 7.5 mm in all sessions. During the protocol, the individuals performed static and dynamic squats, with one static and one dynamic session (interleaved). The variables were evaluated before and after the interventions.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals with a confirmed diagnosis of Metabolic Syndrome according to the International Diabetes Federation criteria;
* Aged over 45 years,
* Both sexes.

Exclusion Criteria

* Uncontrolled untreated hypertension, with elevated systemic blood pressure levels (≥180 x 110 mmHg);
* History of a cardiovascular event (myocardial infarction/stroke) in the last 6 months;
* Deep vein thrombosis while taking medication (6 months);
* History of recent surgery on the lower limbs or spine (within 1 year);
* Neurological, rheumatological, or osteomyoarticular disorders;
* Severe or disabling diseases; individuals with metallic prostheses;
* Individuals unable to undergo the proposed assessments and/or interventions;
* Infectious, neurodegenerative, or pulmonary diseases;
* Individuals who discontinued the intervention (more than three consecutive absences from sessions);
* Individuals presenting any contraindication to the vibratory platform.

Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No